Ładuje się......
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer
PURPOSE: Regorafenib, an oral multi-targeted tyrosine kinase inhibitor, is considered the new standard of care in patients with chemotherapy-refractory colorectal cancers (CRCs). However, there are no data on this drug in Korean patients. MATERIALS AND METHODS: We evaluated patients who received ora...
Zapisane w:
| Wydane w: | Cancer Res Treat |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Korean Cancer Association
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4614225/ https://ncbi.nlm.nih.gov/pubmed/25672574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.126 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|